Federal Court Blocks Overseas Drug Imports, Upholding Gilead's Stance on Patient Safety and FDA Oversight AstraZeneca’s CEO Says AI Is Redefining How New Medicines Are Built Why Barclays Still Sees Eli Lilly as the Undisputed Champion in the Exploding GLP-1 Arena, Even as Rivals Crowd In Navigating the Tides: The Critical Market Watchpoints This Week